SPECTRA PRODS INC (SSA.CA) Stock Fundamental Analysis

Canada • TSX Venture Exchange • TSX-V:SSA • CA84757D2095

0.2 CAD
+0.02 (+8.11%)
Last: Jan 30, 2026, 07:00 PM
Fundamental Rating

5

SSA gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 5 industry peers in the Automobile Components industry. SSA has an excellent financial health rating, but there are some minor concerns on its profitability. SSA does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year SSA was profitable.
  • SSA had a positive operating cash flow in the past year.
  • SSA had positive earnings in each of the past 5 years.
  • Each year in the past 5 years SSA had a positive operating cash flow.
SSA.CA Yearly Net Income VS EBIT VS OCF VS FCFSSA.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K

1.2 Ratios

  • SSA's Return On Assets of 4.46% is amongst the best of the industry. SSA outperforms 100.00% of its industry peers.
  • SSA has a Return On Equity of 5.25%. This is comparable to the rest of the industry: SSA outperforms 60.00% of its industry peers.
  • SSA's Return On Invested Capital of 4.80% is on the low side compared to the rest of the industry. SSA is outperformed by 80.00% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for SSA is above the industry average of 6.17%.
Industry RankSector Rank
ROA 4.46%
ROE 5.25%
ROIC 4.8%
ROA(3y)8.04%
ROA(5y)11.02%
ROE(3y)9.81%
ROE(5y)13.13%
ROIC(3y)8.5%
ROIC(5y)12.06%
SSA.CA Yearly ROA, ROE, ROICSSA.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

1.3 Margins

  • SSA's Profit Margin of 5.73% is amongst the best of the industry. SSA outperforms 100.00% of its industry peers.
  • In the last couple of years the Profit Margin of SSA has declined.
  • SSA has a Operating Margin of 7.49%. This is in the better half of the industry: SSA outperforms 80.00% of its industry peers.
  • SSA's Operating Margin has declined in the last couple of years.
  • SSA's Gross Margin of 46.27% is amongst the best of the industry. SSA outperforms 100.00% of its industry peers.
  • SSA's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 7.49%
PM (TTM) 5.73%
GM 46.27%
OM growth 3Y-25.85%
OM growth 5Y-13.88%
PM growth 3Y-15.05%
PM growth 5Y-23.9%
GM growth 3Y-5.9%
GM growth 5Y-3.54%
SSA.CA Yearly Profit, Operating, Gross MarginsSSA.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

10

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), SSA is creating some value.
  • SSA has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for SSA has been reduced compared to 5 years ago.
  • The debt/assets ratio for SSA has been reduced compared to a year ago.
SSA.CA Yearly Shares OutstandingSSA.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
SSA.CA Yearly Total Debt VS Total AssetsSSA.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M

2.2 Solvency

  • An Altman-Z score of 4.43 indicates that SSA is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 4.43, SSA belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
  • SSA has a debt to FCF ratio of 0.89. This is a very positive value and a sign of high solvency as it would only need 0.89 years to pay back of all of its debts.
  • SSA has a better Debt to FCF ratio (0.89) than 100.00% of its industry peers.
  • SSA has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.05, SSA belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 0.89
Altman-Z 4.43
ROIC/WACC0.58
WACC8.29%
SSA.CA Yearly LT Debt VS Equity VS FCFSSA.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500K -500K 1M 1.5M

2.3 Liquidity

  • SSA has a Current Ratio of 8.67. This indicates that SSA is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Current ratio value of 8.67, SSA belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • SSA has a Quick Ratio of 7.57. This indicates that SSA is financially healthy and has no problem in meeting its short term obligations.
  • SSA has a Quick ratio of 7.57. This is amongst the best in the industry. SSA outperforms 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 8.67
Quick Ratio 7.57
SSA.CA Yearly Current Assets VS Current LiabilitesSSA.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M

1

3. Growth

3.1 Past

  • The earnings per share for SSA have decreased by -4.17% in the last year.
  • SSA shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -27.10% yearly.
  • SSA shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.53%.
  • The Revenue has been decreasing by -4.04% on average over the past years.
EPS 1Y (TTM)-4.17%
EPS 3Y-13.54%
EPS 5Y-27.1%
EPS Q2Q%0%
Revenue 1Y (TTM)8.53%
Revenue growth 3Y-0.72%
Revenue growth 5Y-4.04%
Sales Q2Q%22.7%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SSA.CA Yearly Revenue VS EstimatesSSA.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M

2

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 20.00, the valuation of SSA can be described as rather expensive.
  • Based on the Price/Earnings ratio, SSA is valued more expensive than 80.00% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of SSA to the average of the S&P500 Index (28.18), we can say SSA is valued slightly cheaper.
Industry RankSector Rank
PE 20
Fwd PE N/A
SSA.CA Price Earnings VS Forward Price EarningsSSA.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, SSA is valued a bit cheaper than the industry average as 80.00% of the companies are valued more expensively.
  • 80.00% of the companies in the same industry are cheaper than SSA, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 14.38
EV/EBITDA 3.37
SSA.CA Per share dataSSA.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.02 0.04 0.06 0.08 0.1

4.3 Compensation for Growth

  • The decent profitability rating of SSA may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • SSA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

SPECTRA PRODS INC

TSX-V:SSA (1/30/2026, 7:00:00 PM)

0.2

+0.02 (+8.11%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners26.6%
Inst Owner ChangeN/A
Ins Owners8.25%
Ins Owner ChangeN/A
Market Cap2.73M
Revenue(TTM)1.74M
Net Income(TTM)99.60K
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 20
Fwd PE N/A
P/S 1.57
P/FCF 14.38
P/OCF 14.38
P/B 1.44
P/tB 1.44
EV/EBITDA 3.37
EPS(TTM)0.01
EY5%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.01
FCFY6.95%
OCF(TTM)0.01
OCFY6.95%
SpS0.13
BVpS0.14
TBVpS0.14
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0.18
Profitability
Industry RankSector Rank
ROA 4.46%
ROE 5.25%
ROCE 6.53%
ROIC 4.8%
ROICexc 18.9%
ROICexgc 18.9%
OM 7.49%
PM (TTM) 5.73%
GM 46.27%
FCFM 10.91%
ROA(3y)8.04%
ROA(5y)11.02%
ROE(3y)9.81%
ROE(5y)13.13%
ROIC(3y)8.5%
ROIC(5y)12.06%
ROICexc(3y)25.04%
ROICexc(5y)32.76%
ROICexgc(3y)25.04%
ROICexgc(5y)32.76%
ROCE(3y)11.57%
ROCE(5y)16.41%
ROICexgc growth 3Y-19.46%
ROICexgc growth 5Y-7.33%
ROICexc growth 3Y-19.46%
ROICexc growth 5Y-7.33%
OM growth 3Y-25.85%
OM growth 5Y-13.88%
PM growth 3Y-15.05%
PM growth 5Y-23.9%
GM growth 3Y-5.9%
GM growth 5Y-3.54%
F-Score6
Asset Turnover0.78
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 0.89
Debt/EBITDA 0.52
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 21
Cash Conversion 100.21%
Profit Quality 190.46%
Current Ratio 8.67
Quick Ratio 7.57
Altman-Z 4.43
F-Score6
WACC8.29%
ROIC/WACC0.58
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)225.95%
Profit Quality(5y)198%
High Growth Momentum
Growth
EPS 1Y (TTM)-4.17%
EPS 3Y-13.54%
EPS 5Y-27.1%
EPS Q2Q%0%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)8.53%
Revenue growth 3Y-0.72%
Revenue growth 5Y-4.04%
Sales Q2Q%22.7%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y19.45%
EBIT growth 3Y-26.38%
EBIT growth 5Y-17.36%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-37.62%
FCF growth 3Y-7.27%
FCF growth 5Y-9.48%
OCF growth 1Y-37.62%
OCF growth 3Y-7.27%
OCF growth 5Y-9.92%

SPECTRA PRODS INC / SSA.CA FAQ

What is the fundamental rating for SSA stock?

ChartMill assigns a fundamental rating of 5 / 10 to SSA.CA.


Can you provide the valuation status for SPECTRA PRODS INC?

ChartMill assigns a valuation rating of 2 / 10 to SPECTRA PRODS INC (SSA.CA). This can be considered as Overvalued.


What is the profitability of SSA stock?

SPECTRA PRODS INC (SSA.CA) has a profitability rating of 6 / 10.


What are the PE and PB ratios of SPECTRA PRODS INC (SSA.CA) stock?

The Price/Earnings (PE) ratio for SPECTRA PRODS INC (SSA.CA) is 20 and the Price/Book (PB) ratio is 1.44.


Can you provide the financial health for SSA stock?

The financial health rating of SPECTRA PRODS INC (SSA.CA) is 10 / 10.